Get startedLog in
    Picture of Novo Nordisk A/S logo

    NVO — Novo Nordisk A/S News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapSuper Stock
    All News

    Brief: Orbis Medicines Enters Drug Discovery Partnership With Novo Worth Up To $1.4 Bln

    Picture of Novo Nordisk A/S logoNovo Nordisk A/S
    17/09/2026 12:00
    BRIEF-Orbis Medicines Enters Drug Discovery Partnership With Novo Worth Up To $1.4 Bln
    Sept 17 (Reuters) - Orbis Medicines:
    • ORBIS MEDICINES: NOVO NORDISK TO MAKE STRATEGIC INVESTMENT IN CO
    • ORBIS MEDICINES: AGREEMENT INCLUDES ADDITIONAL TIERED ROYALTIES ON FUTURE PRODUCT SALES
    • ORBIS MEDICINES: COLLABORATION TO DEVELOP ORALLY BIOAVAILABLE MACROCYCLE DRUG CANDIDATES FOR CARDIOMETABOLIC TARGETS
    • ORBIS MEDICINES: ENTERS MULTI-TARGET DRUG DISCOVERY PARTNERSHIP WITH NOVO NORDISK WORTH UP TO $1.4 BILLION
    Further company coverage: [NOVOb.CO]

     ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Novo Nordisk A/S

    See all news